Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the CrossBoss First Trial
Sponsor: Deborah Heart and Lung Center
This PHASE4 trial investigates Arteriosclerosis and Coronary Artery Disease and is currently completed. Deborah Heart and Lung Center leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Feb 2018 — Jun 2018 [monthly]
Completed PHASE4
▶ Show 3 earlier versions
-
Nov 2017 — Feb 2018 [monthly]
Completed PHASE4
-
Sep 2017 — Nov 2017 [monthly]
Completed PHASE4
Status: Enrolling By Invitation → Completed
-
Jan 2017 — Sep 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Deborah Heart and Lung Center
- Henry Ford Hospital
- Massachusetts General Hospital
- Minneapolis Heart Institute
- Missouri Heart Center
- North Central Heart-Avera Sacred Heart Hospital
- North Texas Veterans Healthcare System
- Saint Lukes Hospital Mid America Heart Institute
- United Heart and Vascular Clinic and United Hospital
- University of Washington
- Wellspan Heart and Vascular
For direct contact, visit the study record on ClinicalTrials.gov .